Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Moderna
MRNA
$57.9B
| $2.05M | 0.05% |
14,335
+8,502
| +146% | +$1.22M |
|
502
CALL
Lam Research
LRCX
$393B
| $2.05M | 0.05% |
48,000
+16,000
| +50% | +$762K |
|
503
Bank of Hawaii
BOH
$3.06B
| $2.04M | 0.05% |
27,443
-11,933
| -30% | -$919K |
|
|
POLY
504
DELISTED
Plantronics, Inc.
POLY
| $2.04M | 0.05% |
+51,330
| New | +$2.04M |
|
|
HOLX
505
DELISTED
Hologic
HOLX
| $2.04M | 0.05% |
+29,359
| New | +$2.18M |
|
506
LivePerson
LPSN
$34.9M
| $2.03M | 0.05% |
9,583
-437
| -4% | -$123K |
|
507
Northrop Grumman
NOC
$78.3B
| $2.03M | 0.05% |
4,234
-4,615
| -52% | -$2.12M |
|
|
SMAR
508
DELISTED
Smartsheet Inc.
SMAR
| $2.02M | 0.05% |
64,105
+24,101
| +60% | +$999K |
|
509
Teladoc Health
TDOC
$1.16B
| $2.01M | 0.05% |
+60,557
| New | +$2.57M |
|
510
Delek US
DK
$4.38B
| $2.01M | 0.05% |
+77,749
| New | +$2.1M |
|
511
CALL
Qualcomm
QCOM
$169B
| $2M | 0.05% |
15,700
+10,500
| +202% | +$1.43M |
|
|
LGAC
512
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $1.99M | 0.05% |
203,322
| – | – |
|
513
Archer Daniels Midland
ADM
$38.7B
| $1.99M | 0.05% |
25,664
+9,000
| +54% | +$787K |
|
514
CALL
Johnson & Johnson
JNJ
$651B
| $1.99M | 0.05% |
11,200
+4,900
| +78% | +$873K |
|
|
CRHC
515
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $1.99M | 0.05% |
199,998
| – | – |
|
516
Broadcom
AVGO
$1.75T
| $1.98M | 0.05% |
40,830
-4,960
| -11% | -$278K |
|
|
VISN
517
Vistance Networks Inc
VISN
$2.59B
| $1.98M | 0.05% |
324,153
-116,215
| -26% | -$812K |
|
518
Delta Air Lines
DAL
$54.2B
| $1.98M | 0.05% |
68,462
-92,965
| -58% | -$3.54M |
|
519
Range Resources
RRC
$9.59B
| $1.98M | 0.05% |
80,061
+57,024
| +248% | +$1.75M |
|
|
KCGI
520
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $1.98M | 0.05% |
200,000
| – | – |
|
521
Tetra Tech
TTEK
$9.47B
| $1.97M | 0.05% |
72,235
-25,395
| -26% | -$696K |
|
|
AIMAU
522
DELISTED
Aimfinity Investment Corp I Unit
AIMAU
| $1.97M | 0.05% |
+200,000
| New | +$1.99M |
|
523
Dime Commercial Bancshares
DCOM
$1.79B
| $1.97M | 0.05% |
+66,275
| New | +$2.11M |
|
524
MaxLinear
MXL
$6.04B
| $1.97M | 0.05% |
57,833
+5,295
| +10% | +$222K |
|
525
Dave & Buster's
PLAY
$357M
| $1.96M | 0.05% |
+59,913
| New | +$2.4M |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.